Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China-Biotics and Sinovac Biotech Benefit From China's Biotech Revolution
Yahoo/MarketWire
Saturday, May 28, 2011 - 11:54am
tags:
China-Biotics, Sinovac Biotech
Biotech Stock Mailbag: Fibrocell Science
The Street
Saturday, May 28, 2011 - 11:52am
tags:
Fibrocell Science, laViv, dermal fillers, Botox
AZ: No more free trips for doctors
Fierce Pharma
Friday, May 27, 2011 - 12:11pm
tags:
AstraZeneca, David Brennan, physicians
J&J Now the “Best Biotech Play”, Says Goldman
Barron's
Friday, May 27, 2011 - 12:09pm
tags:
JNJ, biotech, Abbott Laboratories
Cutting Up Pfizer May Just Make a Big Mess
Seeking Alpha
Friday, May 27, 2011 - 11:32am
tags:
Pfizer, reorganization
Investors Should Take Notice of Congressional Questions Regarding Nuedexta Pricing
Seeking Alpha
Friday, May 27, 2011 - 10:54am
tags:
investors, Nuedexta, PBA, Avanir, drug pricing
Full Steam Ahead for Spectrum Pharmaceuticals
Seeking Alpha
Friday, May 27, 2011 - 10:52am
tags:
Spectrum Pharmaceuticals, Teva Pharmaceuticals
A Hidden Reason Why Eli Lilly's Earnings Are Outstanding
Motley Fool
Friday, May 27, 2011 - 10:51am
tags:
Eli Lilly, earnings
It May Be Time for Amylin and Lilly to Head to Divorce Court
Seeking Alpha
Friday, May 27, 2011 - 10:50am
tags:
Eli Lilly, Amylin, restraining order, Alkermes, Bristol-Myers Squibb, Elan, GSK, JNJ, Lexicon Pharmaceuticals, Novo Nordisk, Takeda
The Supreme Court & How To Delay Generics, Pt. 2
Pharmalot
Friday, May 27, 2011 - 9:10am
tags:
generics, Supreme Court, Hatch Waxman Act
MAP Pharma files NDA for migraine drug
Pharmaceutical Business Review
Friday, May 27, 2011 - 9:04am
tags:
migraines, MAP Pharmaceuticals, Levadex
Emergent expects large anthrax vaccine order
Yahoo/AP
Friday, May 27, 2011 - 8:58am
tags:
Emergent BioSolutions, anthrax, vaccines, BioThrax
Arena shares rise on analysis of obesity drug data
Yahoo/AP
Friday, May 27, 2011 - 8:57am
tags:
obesity, Arena Pharmaceuticals
Labeling and Script Use May Cause Problems For Optimer's New Drug
Seeking Alpha
Friday, May 27, 2011 - 8:56am
tags:
Optimer, fidaxomicin, FDA, Clostridium Difficile
Ardea shares climb after release of study results
Yahoo/AP
Friday, May 27, 2011 - 8:54am
tags:
lesinurad, Ardea, gout
Cubist Pharma rises on speculation about potential sale to Irish drugmaker Shire
Yahoo/AP
Friday, May 27, 2011 - 8:53am
tags:
Shire, M&A, Cubist Pharmaceuticals
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Minyanville
Friday, May 27, 2011 - 8:53am
tags:
JNJ, Edurant, Zytiga, prostate cancer, HIV, AIDS
Abbott's Niaspan Setback May Reverberate With Merck
WSJ Online
Friday, May 27, 2011 - 8:50am
tags:
Abbott Laboratories, Merck, Niaspan, cholesterol
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem
Seeking Alpha
Thursday, May 26, 2011 - 12:30pm
tags:
Athersys, MultiStem, graft vs host disease
Vertex to field small, specialized sales force on Incivek
Fierce Pharma
Thursday, May 26, 2011 - 12:27pm
tags:
drug reps, sales force, Vertex Pharmaceuticals, hepatitis C, Incivek

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.